Synapse Open Synapse
Biology

STAT+: PepGen says early trial for muscular dystrophy drug looks promising

STAT News · · 1 min read

PepGen says its candidate is correcting more of the genetic stutter found in myotonic dystrophy type 1.

Latest from STAT News